Inhibition of LPS-induced nitric oxide production by transduced Tat-arginine deiminase fusion protein in Raw 264.7 cells

BMB Reports

Volumn 42, Issue 5, 2009, Pages 286-292

  Lee, Min Jung ^a   Kim, Dae Won ^a   Lee, Yeom Pyo ^a   Jeong, Hoon Jae ^a   Kang, Hye Won ^a   Shin, Min Jae ^a   Sohn, Eun Jeong ^a   Kim, Mi Jin ^a   Jang, Sang Ho ^a   Kang, Tae Cheon ^b   Won, Moo Ho ^b   Min, Bon Hong ^c   Cho, Sung Woo ^d   Lee, Kil Soo ^a   Park, Jinseu ^a   Eum, Won Sik ^a   Choi, Soo Young ^a  

^a Department of Biomedical Science and Research Institute for Bioscience and Biotechnology ^*  (South Korea)

^b Hallym University   (South Korea)

^c Korea University College of Medicine   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

Author keywords

Arginine deiminase (ADI); HIV 1 Tat peptide; Inflammation; Nitric oxide synthase; Protein transduction

Indexed keywords

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 66549086521     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2009.42.5.286     Document Type: Article

References (46)

1. Zuniga, M., Perez. G. and Gonzalez-Candelas, F. (2002) Evolution of arginine deiminase (ADI) pathway genes. Mol. Phylogenet. Evol. 25, 429-444.
2. Cumin, R., Glansdorff, N., Pierard, A. and Stalon, V. (1986) Biosynthesis and metabolism of arginine in bacteria. Microbiol. Rev. 50, 314-352.
3. Gong, H., Zolzer, F., von Recklinghausen, G., Havers, W. and Schweigerer, L. (2000) Arginine deiminase inhibits proliferation of human leukemia cells more potently than asparaginase by inducing cell cycle arrest and apoptosis. Leukemia 14, 826-829.
4. Komada, Y., Zhang, X. L., Zhou, Y. W., Ido, M. and Azuma, E. (1997) Apoptotic cell death of human T lymphoblastoid cells induced by arginine deiminase. Int. J. Hematol. 65, 129-141.
5. Takaku, H., Takase, M., Abe, S., Hayashi, H. and Miyazaki, K. (1992) In vivo anti-tumor activity of arginine deiminase purified from Mycoplasma arginini. Int. J. Cancer 51, 244-249.
6. Ensor, C. M., Holtsberg, F. W., Bomalaski, J. S. and Clark, M. A. (2002) Pegylated arginine deiminase (ADI-SSPEG 20,000 MW) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo. Cancer Res. 62, 5443-5450.
7. Kang, S. W., Kang, H., Park, I. S., Choi, S. H., Shin, K. H., Chun, Y. S., Chun, B. G. and Min, B. H. (2000) Cytoprotective effect of arginine deiminase on taxol-induced apoptosis in DU145 human prostate cancer cells. Mol. Cells 10, 331-337.
8. Noh, E. J., Kang, S. W., Shin, Y. J., Kim, D. C., Park, I. S., Kim, M. Y., Chun, B. G. and Min, B. H. (2002) Characterization of mycoplasma arginine deiminase expressed in E. coli and its inhibitory regulation of nitric oxide synthesis. Mol. Cells 13, 137-143.
9. Muller, H. J. and Boos, J. (1998) Use of L-asparaginase in childhood ALL. Crit. Rev. Oncol. Hematol. 28, 97-113.
10. Curley, S. A., Bomalaski, J. S., Ensor, C. M., Holtsberg, F. W. and Clark, M. A. (2003) Regeneration of hepatocellular cancer in a patient treated with arginine deiminase. Hepatogastroenterol. 50, 1214-1216.
11. Shen, L. J., Beloussow, K. and Shen, W. C. (2006) Modulation of arginine metabolic pathways as the potential anti-tumor mechanism of recombinant arginine deimiase. Cancer Lett. 231, 30-35.
12. Ni, Y., Schwaneberg, U. and Sun, Z. H. (2008) Arginine deiminase, a potential anti-tumor drug. Cancer Lett. 261, 1-11.
13. Yu, H. H., Wu, F. L., Lin, S. E. and Shen, L. J. (2008) Recombinant arginine deiminase reduces inducible nitric oxide synthase iNOS-mediated neurotoxicity in a co-culture of neurons and microglia. J. Neurosci. Res. 86, 2963-2972.
14. Colton, C. A., Vitek, M. P., Wink, D. A., Xu, Q., Cantillana, V., Previti, M. L., van Nostrand, W. E., Weinberg, J. B. and Dawson, H. (2006) NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 103, 12867-12872.
15. Dawson, V. L., Kizushi, V. M., Huang, P. L., Snyder, S. H. and Dawson, T. M. (1996) Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J. Neurosci. 16, 2479-2487.
16. Good, P. F., Hsu, A., Werner, P., Perl, D. P. and Olanow, C. W. (1998) Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol. 57, 338-342.
17. Huang, Z., Huang, P. L., Panahian, N., Dalkara, T., Fishman M. C. and Moskowitz, M. A. (1994) Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265, 1883-1885.
18. Iadecola, C., Zhang, F., Casey, R., Nagayama, M. and Ross, M. E. (1997) Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J. Neurosci. 17, 9157-9164.
19. Martin, L. J., Liu, Z., Chen, K., Price, A. C., Pan, Y., Swa by, J. A. and Golden, W. C. (2007) Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanism of mitochondriopathy and cell death. J. Comp. Neurol. 500, 20-46.
20. Amin, A. R., Attur, M. and Abramson, S. B. (1999) Nitric oxide synthase and cyclooxygenases: distribution, regulation, and intervention in arthritis. Curr. Opin. Rheumatol. 11, 202-209.
21. Rietschel, E. T., Kirikae, T., Schade, F. U., Mamat, U., Schmidt, G., Loppnow, H., Ulmer, A. J., Zahringer, U., Seydel, U. and Di Padova, F. (1994) Bacterial endotoxin: molecular relationships and structure to activity and function. FASEB J. 8, 217-225.
22. Morrison, D. C. and Ryan, J. L. (1987) Endotoxins and disease mechanisms. Annu. Rev. Med. 38, 417-432.
23. Adams, D. O. and Hamilton, T. A. (1984) The cell biology of macrophage activation. Annu. Rev. Immunol. 2, 283-318.
24. Wadia, J. and Dowdy, S. F. (2002) Protein transduction technology. Curr. Opin. Biotechnol. 13, 52-56.
25. Morris, M. C., Depollier, J., Mery, J., Heitz, F. and Divita, G. (2001) A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 19, 1173-1176.
26. Schwarze, S. R., Ho, A., Vocero-Akbani, A. and Dowdy, S. R. (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285, 1569-1572.
27. Prochiantz, A. (2000) Messenger proteins: homeoproteins, TAT and others. Curr. Opin. Cell Biol. 12, 400-406.
28. Kwon, H. Y., Eum, W. S., Jang, H. W., Kang, J. H., Ryu, J. Y., Lee, B. R., Jin, L. H., Park, J. and Choi, S. Y. (2000) Transduction of Cu,Zn-superoxide dismutase mediated by an HIV-1 Tat protein basic domain into mammalian cells. FEBS Lett. 485, 163-167.
29. Eum W. S., Choung, I. S., Li, M. Z., Kang, J. H., Kim, D. W., Park, J., Kwon, H. Y. and Choi, S. Y. (2004) HIV-1 Tat mediated protein transduction of Cu,Zn-superoxide dismutase into pancreatic β cells in vitro and in vivo. Free Radic. Biol. Med. 37, 339-349.
30. Choi, H. S., An, J. J., Kim, S. Y., Lee, S. H., Kim, D. W., Yoo, K. Y., Won, M. H., Kang, T. C., Kwon, H. J., Kang, J. H., Cho, S. W., Kwon, O. S., Park, J., Eum, W. S. and Choi, S. Y. (2006) PEP-1-SOD fusion protein efficiently protects against paraquat-induced dopaminergic neuron damage in a Parkinson disease mouse model. Free Radic. Biol. Med. 41, 1058-1068.
31. Eum, W. S., Kim D. W., Hwang, I. K., Yoo, K. Y., Kang, T. C., Jang, S. H., Choi, H. S., Choi, S. H., Kim, Y. H., Kim, S. Y., Kwon, H. Y., Kang, J. H., Kwon, O. S., Cho, S. W., Lee, K. S., Park, J., Won, M. H. and Choi, S. Y. (2004) In vivo protein transduction: biologically active intact PEP-1-superoxide dismutase fusion protein efficiently protects against ischemic insult. Free Radic. Biol. Med. 37, 1656-1669.
32. Jeong, M. S., Kim, D. W., Lee, M. J., Lee, Y. P., Kim, S. Y., Lee, S. H., Jang, S. H., Lee, K. S., Park, J., Kang, T. C., Cho, S. W., Kwon, O. S., Eum, W. S. and Choi, S. Y. (2008) HIV-1 Tat-mediated protein transduction of human brain creatine kinase into PC12 cells. BMB reports 41, 537-541.
33. Lee, Y. P., Kim, D. W., Lee, M. J., Jeong, M. S., Kim, S. Y., Lee, S. H., Jang, S. H., Park, J., Kang, T. C., Won, M. H., Cho, S. W., Kwon, O. S., Eum, W. S. and Choi, S. Y. (2008) Human brain pyridoxal-5'-phosphate phosphatase (PLPP): protein transduction of PEP-1-PLPP into PC12 cells. BMB reports 41, 408-413.
34. Kim, D. W., Kim, S. Y., Lee, S. H., Lee, Y. P., Lee, M. J., Jeong, M. S., Jang, S. H., Park, J., Lee, K. S., Kang, T. C., Won, M. H., Cho, S. W., Kwon, O. S., Eum, W. S. and Choi, S. Y. (2008) Protein transduction of an antioxidant enzyme: subcellular localization of superoxide dismutase fusion protein in cells. BMB reports 41, 170-175.
35. Richard, J. P., Melikov, K., Vives, E., Rmos, C., Vereure, B., Gait, M. J., Chernomordik, L. V. and Lebleu, B. (2003) Cell penetrating peptides: a reevaluaation of the mechanism of cellular uptake. J. Biol. Chem. 278, 585-590.
36. Cashman, S. M., Morris, D. J., and Kuman-Singh, R. (2003). Evidence of protein transduction but not intracellular by protein fused to HIV Tat in retinal cell culture and in vivo. Mol. Ther. 8, 130-142.
37. Dillon, B. J., Holtsberq, F. W., Ensor, C. M., Bomalaski, J. S. and Clark, M. A. (2002) Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide production. Med. Sci. Monit. 8, BR248-253.
38. Shen, L. J., Lin, W. C., Beloussow, K. and Shen, W. C. (2003) Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase. Cancer Lett. 191, 165-170.
39. Shen, L. J. and Shen, W. C. (2006) Drug evaluation: ADIPEG-20-a PEGylated arginine deiminase for arginine-auxotrophic cencers. Curr. Opin. Mol. Ther. 8, 240-248.
40. Gong, H., Pottgen, C., Stuben, G., Havers, W., Stuschke, M. and Schweigerer, L. (2003) Arginine deiminase and other antiangiogenic agents inhibit unfavorable neuroblastoma growth: potentiation by irradiation. Int. J. Cancer 106, 723-728.
41. van Rijn, J., van den Berg, J., Schipper, R. G., de Jong, S., Cuijpers, V., Verhofstad, A. A. and Teerlink, T. (2004) Induction of hyperammonia in irradiated hepatoma cells: a recapitulation and possible explanation of the phenomenon. Br. J. Cancer 91, 150-152.
42. Park, H., Lee, J. B., Shim, Y. J., Shin, Y. J., Jeong, S. Y., Oh, J., Park, G. H., Lee, K. H. and Min, B. H. (2008) Arginine deiminase enhances MCF-7 cell radiosensitivity by inducing changes in the expression of cell cycle-related proteins. Mol. Cells 25, 305-311.
43. Bradford, M. (1976) A rapid and sensitive method for the quantitation of microgram quantities utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
44. Boyde, T. R. and Mohammed, R. (1980) Optimization of conditions for the colorimetic determination of citrulline, using deacetyl monoxime. Anal. Biochem. 107, 424-431.
45. Misko, T. P., Schilling, R. J., Salvemini, D., Moore, W. M. and Currie, M. G. (1993) A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem. 214, 11-16.
46. Kim, J. E., Hur, H. J., Lee, K. W. and Lee, H. J. (2007) Anti-inflammatory effects of recombinant arginine deiminase originating from Lactococus lactis ssp.lactis ATCC 7962. J. Microbiol. Biotechnol. 17, 1491-1497.